Neosoma Announces Receiving FDA 510(k) Clearance for Brain Mets
Neosoma, a best-in-class provider of AI-based brain tumor analysis medical software, receives FDA 510(k) clearance for its Brain Mets product.…
“We Three Kings: The Story Behind the Story” Makes Off-Broadway Debut, Introducing a New Dramatic Voice to the Holiday Canon
Original Play by Solon Phillips Explores Faith, Loss, and Redemption Through a Human Reimagining of the Magi NEW YORK, Dec.…
100 Black Men of America, Inc. Joins National HOPE AI Initiative to Advance Inclusive Financial and AI Literacy Across Underserved Communities
ATLANTA, Dec. 23, 2025 /PRNewswire/ — 100 Black Men of America, Inc., the nation’s preeminent African American mentoring and leadership development…
Xiao-I Corporation Announces Receipt of Nasdaq Listing Deficiency Notices
SHANGHAI, Dec. 23, 2025 /PRNewswire/ — Xiao-I Corporation (NASDAQ: AIXI) (the “Company”) today announced that it has received two written notifications…
Princess Cruises Christens Star Princess Tournament of Roses Float With Celebration Ambassador Jill Whelan
IMAGES AND B-ROLL MEDIA KIT PASADENA, Calif., Dec. 23, 2025 /PRNewswire/ — Princess Cruises embraced a cherished maritime tradition in…
Akins Ford Debuts Comprehensive Deep Dive into the 2026 Ford Bronco Big Bend
Akins Ford provides Georgia drivers with an exclusive look at the latest performance upgrades and availability for the highly anticipated…
Simmons First National Corporation Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
PINE BLUFF, Ark., Dec. 23, 2025 /PRNewswire/ — Simmons First National Corporation (NASDAQ: SFNC) today announced it is scheduled to…
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
Cancer Immunotherapy, LYMPHIR™, launched in the U.S. in December 2025 Completed $36 million in strategic financings, of which $18 million…
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR™, in the U.S. in December 2025 CRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ —…
pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026
METUCHIN, N.J., Dec. 23, 2025 /PRNewswire/ — As 2026 approaches, podiatrists, chiropractors, and dentists are facing a rapidly evolving digital…
CCSC Technology International Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2025
HONG KONG, Dec. 23, 2025 /PRNewswire/ — CCSC Technology International Holdings Limited (the “Company” or “CCSC”) (Nasdaq: CCTG), a Hong…
Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche
CALGARY, AB, Dec. 23, 2025 /PRNewswire/ – Nanalysis Scientific Corp. (the “Company” or “Nanalysis“) (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased…
Aimco Closes Sale of Brickell Assemblage and Enters Agreement to Sell Two Additional Properties
DENVER, Dec. 23, 2025 /PRNewswire/ — Apartment Investment and Management Company (“Aimco”) sold its Brickell Assemblage, which includes The Yacht…
U.S. Government Leaders Join the CES 2026 Lineup
ARLINGTON, Va., Dec. 23, 2025 /PRNewswire/ — The Consumer Technology Association (CTA)® today announces high profile additions to the list of…
GENOMMA LAB INTERNACIONAL ANNOUNCES FOURTEENTH DIVIDEND PAYMENT
MEXICO CITY, Dec. 23, 2025 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), one of…
↑